Literature DB >> 11148548

The nutritional management of urea cycle disorders.

J V Leonard1.   

Abstract

Diet is one of the mainstays of the treatment of patients with urea cycle disorders. The protein intake should be adjusted to take account of the inborn error and its severity and the patient's age, growth rate, and individual preferences. Currently, the widely used standards for protein intake are probably more generous than necessary, particularly for those with the more severe variants. Most patients, except those with arginase deficiency, will need supplements of arginine, but the value of other supplements including citrate and carnitine is unclear. Any patient on a low-protein diet should be monitored clinically and with appropriate laboratory tests. All should have an emergency (crisis) regimen to prevent decompensation during periods of metabolic stress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11148548     DOI: 10.1067/mpd.2001.111835

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Long-term outcome and intervention of urea cycle disorders in Japan.

Authors:  Jun Kido; Kimitoshi Nakamura; Hiroshi Mitsubuchi; Toshihiro Ohura; Masaki Takayanagi; Masafumi Matsuo; Makoto Yoshino; Yosuke Shigematsu; Tohru Yorifuji; Mureo Kasahara; Reiko Horikawa; Fumio Endo
Journal:  J Inherit Metab Dis       Date:  2011-12-14       Impact factor: 4.982

Review 2.  Nutritional management of patients with urea cycle disorders.

Authors:  R H Singh
Journal:  J Inherit Metab Dis       Date:  2007-11-25       Impact factor: 4.982

3.  On the Creation, Utility and Sustaining of Rare Diseases Research Networks: Lessons learned from the Urea Cycle Disorders Consortium, the Japanese Urea Cycle Disorders Consortium and the European Registry and Network for Intoxication Type Metabolic Diseases.

Authors:  Marshall L Summar; Fumio Endo; Stefan Kölker
Journal:  Mol Genet Metab       Date:  2014 Sep-Oct       Impact factor: 4.797

4.  Amino Acid Profiles in Patients with Urea Cycle Disorders at Admission to Hospital due to Metabolic Decompensation.

Authors:  S Rodney; A Boneh
Journal:  JIMD Rep       Date:  2012-10-30

5.  Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment.

Authors:  Jun Kido; Shirou Matsumoto; Hiroshi Mitsubuchi; Fumio Endo; Kimitoshi Nakamura
Journal:  Metab Brain Dis       Date:  2018-06-11       Impact factor: 3.584

Review 6.  Clinical practice: the management of hyperammonemia.

Authors:  Johannes Häberle
Journal:  Eur J Pediatr       Date:  2010-12-17       Impact factor: 3.183

7.  Effects of arginine treatment on nutrition, growth and urea cycle function in seven Japanese boys with late-onset ornithine transcarbamylase deficiency.

Authors:  Hironori Nagasaka; Tohru Yorifuji; Kei Murayama; Mitsuru Kubota; Keiji Kurokawa; Tomoko Murakami; Masaki Kanazawa; Tomozumi Takatani; Atsushi Ogawa; Emi Ogawa; Shigenori Yamamoto; Masanori Adachi; Kunihiko Kobayashi; Masaki Takayanagi
Journal:  Eur J Pediatr       Date:  2006-05-16       Impact factor: 3.183

8.  Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ.

Authors:  Nicholas Ah Mew; Lauren Krivitzky; Robert McCarter; Mark Batshaw; Mendel Tuchman
Journal:  J Pediatr       Date:  2012-08-15       Impact factor: 4.406

9.  Clinical manifestations and growth of patients with urea cycle disorders in Japan.

Authors:  Kimitoshi Nakamura; Jun Kido; Shirou Matsumoto; Hiroshi Mitsubuchi; Fumio Endo
Journal:  J Hum Genet       Date:  2016-03-03       Impact factor: 3.172

10.  Liver engraftment and repopulation by in vitro expanded adult derived human liver stem cells in a child with ornithine carbamoyltransferase deficiency.

Authors:  Etienne M Sokal; Xavier Stéphenne; Chris Ottolenghi; Nawal Jazouli; Philippe Clapuyt; Florence Lacaille; Mustapha Najimi; Pascale de Lonlay; Françoise Smets
Journal:  JIMD Rep       Date:  2013-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.